Oncopeptides AB (publ) (STO:ONCO)
Sweden · Delayed Price · Currency is SEK 1.570
-0.013 (-0.82%)
Aug 13, 2026, 5:29 PM CET
Oncopeptides AB Market Cap
Oncopeptides AB has a market cap or net worth of 625.74 million as of August 13, 2026. Its market cap has decreased by -38.41% in one year.
Market Cap
625.74M
Enterprise Value
559.39M
Revenue
83.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.57
ChartMarket Cap Chart
Since February 22, 2017, Oncopeptides AB's market cap has decreased from 1.67B to 625.74M, a decrease of -62.52%. That is a compound annual growth rate of -9.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 620.60M | -52.64% |
| Dec 30, 2025 | 1.31B | 291.35% |
| Dec 30, 2024 | 334.83M | -53.79% |
| Dec 29, 2023 | 724.64M | -36.76% |
| Dec 30, 2022 | 1.15B | 81.18% |
| Dec 30, 2021 | 632.45M | -94.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medivir AB | 1.11B |
| SynAct Pharma AB | 1.05B |
| AlzeCure Pharma AB | 926.67M |
| Infant Bacterial Therapeutics AB | 875.64M |
| Xspray Pharma AB | 679.95M |
| FluoGuide | 510.10M |
| Corline Biomedical AB | 466.48M |
| Cantargia AB | 454.96M |